Acetylcholine:

• Function: Acetylcholine is a neurotransmitter that plays diverse roles in the nervous system, including motor control, cognition, and autonomic function. It can also modulate pain transmission by activating nicotinic and muscarinic acetylcholine receptors in the central and peripheral nervous systems.
• Locations: Acetylcholine is released from cholinergic neurons in the brainstem and basal forebrain and acts on its receptors distributed throughout the CNS and peripheral nervous system. In the context of pain modulation, cholinergic neurons project to pain-processing regions in the spinal cord and brain.

Adenosine:

• Function: Adenosine is a neuromodulator that can inhibit neurotransmitter release and reduce neuronal excitability. It plays a role in pain modulation by activating adenosine receptors, particularly the A1 and A2A subtypes, which can attenuate nociceptive transmission and produce analgesic effects.
• Locations: Adenosine is released in response to tissue injury or inflammation and acts on adenosine receptors located in various regions of the CNS, including the spinal cord dorsal horn, periaqueductal gray matter, and thalamus.

Bradykinin:

• Function: Bradykinin is a peptide mediator released during tissue injury and inflammation. It sensitizes nociceptors, enhances the perception of pain, and contributes to neurogenic inflammation by promoting vasodilation and increasing vascular permeability.
• Locations: Bradykinin is generated locally at sites of tissue injury or inflammation and acts on bradykinin receptors located on peripheral sensory nerve terminals, as well as in the spinal cord dorsal horn and brainstem

Calcitonin Gene-Related Peptide (CGRP):

• Function: CGRP is a neuropeptide involved in nociceptive signaling and neurogenic inflammation. It sensitizes nociceptors and promotes vasodilation, contributing to the perception of pain and inflammation.
• Locations: CGRP is synthesized and released from sensory neurons in the dorsal root ganglia and trigeminal ganglia. It acts on CGRP receptors located in the spinal cord dorsal horn, brainstem, and various regions of the brain involved in pain processing.

Cannabinoids:

• Function: Cannabinoids are compounds that interact with cannabinoid receptors, primarily CB1 and CB2 receptors. They modulate pain perception by inhibiting neurotransmitter release and dampening neuronal excitability. Endocannabinoids, such as anandamide and 2-arachidonoylglycerol (2-AG), are produced in the body and act as retrograde messengers to regulate synaptic transmission.
• Locations: Cannabinoid receptors are distributed throughout the CNS and peripheral nervous system, with high concentrations in pain-processing regions of the brain, spinal cord, and peripheral sensory neurons. Endocannabinoids are synthesized on-demand in response to neuronal activity and can act locally or diffusely to modulate pain signaling.

Corticotropin-Releasing Factor (CRF):

• Function: Corticotropin-releasing factor is a neuropeptide involved in stress responses and the regulation of the hypothalamic-pituitary-adrenal (HPA) axis. It can modulate pain perception by influencing emotional processing and stress-induced analgesia.
• Locations: CRF-producing neurons are primarily located in the hypothalamus and amygdala, with projections to various regions of the brain and spinal cord involved in pain processing and stress regulation.

Dopamine:

• Function: Dopamine is a neurotransmitter that plays a crucial role in reward-motivated behavior, motor control, mood regulation, and reinforcement of learning. It’s also involved in the perception of pain.
• Locations: Dopamine-producing neurons are found primarily in the substantia nigra and the ventral tegmental area (VTA) of the midbrain. Projections from these areas extend throughout the brain, including the mesolimbic pathway (involved in reward and pleasure) and the mesocortical pathway (involved in cognitive control and motivation).

Dynorphins:

• Function: Dynorphins are endogenous opioid peptides that interact with kappa opioid receptors (KORs). They modulate pain perception and mood and can produce analgesic effects through KOR activation.
• Locations: Dynorphins are widely distributed throughout the CNS, including the spinal cord, amygdala, and hippocampus. They are released in response to stress and pain and act locally to modulate synaptic transmission.

Endocannabinoid System (e.g., Anandamide, 2-AG):

• Function: Endocannabinoids are lipid signaling molecules that act as retrograde messengers to regulate synaptic transmission. They play a role in pain modulation by activating cannabinoid receptors and inhibiting neurotransmitter release in pain-processing pathways.
• Locations: Endocannabinoids, such as anandamide and 2-arachidonoylglycerol (2-AG), are produced on-demand in response to neuronal activity. They act locally at cannabinoid receptors, primarily CB1 receptors, located on presynaptic terminals in the CNS and peripheral nervous system.

Endorphins and Enkephalins:

• Function: Endorphins and enkephalins are endogenous opioid peptides that act as neuromodulators and neurotransmitters. They bind to opioid receptors and play a significant role in pain modulation, often producing analgesic effects by inhibiting pain transmission.
• Locations: Endorphins and enkephalins are produced in various brain regions, including the hypothalamus and pituitary gland, as well as in peripheral tissues. Opioid receptors are found throughout the CNS, with high concentrations in pain-processing regions, such as the spinal cord, periaqueductal gray (PAG) matter, and rostral ventromedial medulla (RVM).

GABA (Gamma-Aminobutyric Acid):

• Function: GABA is the main inhibitory neurotransmitter in the central nervous system (CNS). It plays a crucial role in regulating neuronal excitability and is involved in reducing neuronal activity. GABAergic signaling can modulate pain perception by inhibiting excitatory neurotransmission.
• Locations: GABAergic neurons are found throughout the CNS, with particularly high concentrations in the cerebral cortex, hippocampus, basal ganglia, and cerebellum. In the context of pain modulation, GABAergic interneurons are present in various pain-processing regions of the spinal cord and brain.

Neuropeptide Y (NPY):

• Function: Neuropeptide Y is a peptide neurotransmitter that acts as an endogenous analgesic by inhibiting pain transmission in the spinal cord and brain. It can also modulate stress responses and emotional processing, influencing pain perception indirectly.
• Locations: Neuropeptide Y is widely distributed throughout the CNS, with particularly high concentrations in regions involved in pain processing, such as the spinal cord dorsal horn, amygdala, and hypothalamus.

Neurotensin:

• Function: Neurotensin is a neuropeptide involved in pain modulation, neurotransmission, and gastrointestinal function. It can modulate nociceptive signaling by interacting with neurotensin receptors in pain-processing regions of the CNS.
• Locations: Neurotensin is synthesized in the CNS, particularly in the hypothalamus and brainstem. It acts on neurotensin receptors expressed by neurons in the spinal cord dorsal horn, periaqueductal gray matter, and other pain-related brain regions.

Neurotrophins (e.g., Nerve Growth Factor, NGF):

• Function: Neurotrophins are growth factors involved in neuronal development, survival, and function. NGF, in particular, plays a role in nociceptive sensitization by promoting the sprouting of sensory nerve fibers, increasing the expression of pain-related receptors, and enhancing neuronal excitability.
• Locations: NGF is synthesized by various cell types, including immune cells, keratinocytes, and fibroblasts, in response to tissue injury or inflammation. It acts on TrkA receptors expressed by sensory neurons in the peripheral nervous system and on pain-processing regions of the CNS.

Nitric Oxide (NO):

• Function: Nitric oxide is a gaseous neurotransmitter involved in numerous physiological processes, including vasodilation, immune regulation, and synaptic transmission. In the context of pain modulation, NO can enhance or inhibit nociceptive signaling depending on its concentration and location.
• Locations: Nitric oxide is produced by neuronal nitric oxide synthase (nNOS) in the CNS and peripheral nervous system. It acts locally within synaptic terminals to modulate neurotransmitter release and neuronal excitability, including in pain-processing pathways.

Norepinephrine (Noradrenaline):

• Function: Norepinephrine is both a neurotransmitter and a stress hormone. It plays a crucial role in the body’s “fight or flight” response, as well as in modulating attention, arousal, mood, and stress responses. In the context of pain, norepinephrine can modulate nociceptive transmission, either enhancing or inhibiting pain perception depending on the receptor subtype activated.
• Locations: Norepinephrine is synthesized in the locus coeruleus, a nucleus in the pons of the brainstem. From there, noradrenergic projections extend throughout the CNS, including the cerebral cortex, limbic system, spinal cord, and various pain-processing regions.

Orexins (Hypocretins):

• Function: Orexins are neuropeptides involved in regulating arousal, wakefulness, and appetite. They also play a role in modulating pain perception by interacting with pain-processing regions of the brain and spinal cord.
• Locations: Orexin-producing neurons are located in the lateral hypothalamus. Orexin receptors are distributed throughout the CNS, including regions involved in pain processing, such as the spinal cord dorsal horn, periaqueductal gray matter, and amygdala.

Oxytocin:

• Function: Oxytocin is a neuropeptide known for its role in social bonding, childbirth, and lactation. It can also modulate pain perception by reducing stress and enhancing social support, which can indirectly influence pain processing.
• Locations: Oxytocin-producing neurons are primarily located in the hypothalamus, with projections to various regions of the brain involved in emotional processing and pain modulation, such as the amygdala and periaqueductal gray matter.

Prostaglandins:

• Function: Prostaglandins are lipid mediators produced in response to tissue injury or inflammation. They sensitize nociceptors and contribute to the perception of pain by lowering the threshold for activation and increasing the responsiveness of pain-sensing neurons.
• Locations: Prostaglandins are synthesized in peripheral tissues, particularly at sites of inflammation, and act locally to enhance pain sensitivity. They can also contribute to central sensitization by modulating synaptic transmission in the spinal cord dorsal horn.

Serotonin (5-Hydroxytryptamine, 5-HT):

• Function: Serotonin is a neurotransmitter and neuromodulator involved in regulating mood, emotion, sleep, appetite, and pain perception. It can modulate pain by inhibiting nociceptive signaling pathways.
• Locations: Serotonergic neurons are primarily located in the raphe nuclei of the brainstem, specifically the dorsal and median raphe nuclei. These neurons send projections throughout the brain and spinal cord, influencing various physiological processes, including pain modulation.

Somatostatin:

• Function: Somatostatin is a neuropeptide with diverse physiological functions, including inhibiting the release of various hormones and neurotransmitters. In the context of pain modulation, somatostatin can inhibit nociceptive signaling in the spinal cord and brain.
• Locations: Somatostatin-producing neurons are found in the CNS, particularly in the hypothalamus, brainstem, and spinal cord dorsal horn. Somatostatin receptors are expressed by neurons involved in pain processing, allowing for modulation of synaptic transmission.

Substance P:

• Function: Substance P is a neuropeptide involved in transmitting pain signals from the periphery to the central nervous system. It is released from nociceptive nerve terminals in response to noxious stimuli and plays a role in neurogenic inflammation and the amplification of pain signals.
• Locations: Substance P is found in sensory neurons of the dorsal root ganglia and is released from peripheral nerve terminals in response to tissue injury or inflammation. It acts on its receptors, known as neurokinin 1 (NK1) receptors, which are located in the spinal cord dorsal horn and various brain regions involved in pain processing, including the amygdala and hypothalamus.

Vasoactive Intestinal Peptide (VIP):

• Function: VIP is a neuropeptide with diverse physiological functions, including regulating blood flow, immune responses, and neurotransmission. In the context of pain modulation, VIP acts as a vasodilator and can inhibit nociceptive signaling in the spinal cord and brain.
• Locations: VIP-producing neurons are found in various regions of the CNS, including the hypothalamus, brainstem, and spinal cord. VIP receptors are expressed by sensory neurons and interneurons in pain-processing pathways.